DCLRE1B and pancreatic adenocarcinoma: In terms of PFS, DCLRE1B expression had a protective role in COAD, GBM, OV, as well as STAD, however, it appeared to be a risk factor in ACC, BLCA, KICH, KIRP, LIHC, MESO, PAAD, PRAD and SARC (Fig. 4D).